What the flux podcast 2'30" mark
Main point; J&J sell 80% of their Kenvue holding banking $32B to utilise on investment in MEDICAL DEVICES/STRATEGIC ACQUISITIONS.
In listening to the recent activity of J&J and their focus on investment in new biotech I couldn't help thinking that PNV fits all of their criteria.
If they're willing to part with a third of their acquired funds from the Kenvue sale I would be a reluctant seller.
https://www.listennotes.com/podcasts/what-the-flux/qantas-ceo-steps-down-qQ4fLh96TFw/
What the flux podcast 2'30" markMain point; J&J sell 80% of...
-
- There are more pages in this discussion • 2,397 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.64 |
Change
-0.010(0.38%) |
Mkt cap ! $1.823B | |||
| Open | High | Low | Value | Volume |
| $2.62 | $2.64 | $2.58 | $2.297M | 877.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2375 | $2.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.64 | 3584 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |